SCHEMBL23677190

SCHEMBL23677190

O=C(Nc1ccc(F)c(Br)c1)c1c(F)ccc([SH](=O)=O)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 3/20 0.40
▸ CA2 P00918 3/20 0.40
▸ CA9 Q16790 2/20 0.40
▸ RAB9A P51151 5/20 0.39
▸ NPC1 O15118 4/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ TP53 P04637 2/20 0.39
▸ BRAF P15056 1/20 0.39
▸ HDAC3 O15379 1/20 0.38
▸ HDAC11 Q96DB2 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ ERBB2 P04626 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ TLR8 Q9NR97 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23677258 0.84 NPC1 (0.55) RAB9ANPC1SMN1; SMN2TSHRALDH1A1
SCHEMBL23677151 0.82 GRM4 (0.52) SMN1; SMN2TP53LMNAHTTTLR7
SCHEMBL23677224 0.81 GRM4 (0.53) RAB9ANPC1SMN1; SMN2TP53ALDH1A1
SCHEMBL23677215 0.77 CA1 (0.54) CA1CA2CA9SMN1; SMN2BRAF
SCHEMBL23677187 0.76 CA1 (0.47) CA1CA2CA9RAB9ASMN1; SMN2
SCHEMBL4117988 0.71 IDO1 (0.48) RAB9ANPC1SMN1; SMN2TSHRIDO1
SCHEMBL149098 0.71 MEN1 (0.63) RAB9ANPC1SMN1; SMN2TP53KMT2A
SCHEMBL147440 0.70 IDO1 (0.65) CA1CA2CA9RAB9ANPC1
SCHEMBL20560649 0.70 IDO1 (0.47) CA2RAB9ANPC1SMN1; SMN2TSHR
SCHEMBL17202417 0.69 CES2 (0.35) CA1CA2CA9SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2890375-B1 SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B JANSSEN SCIENCES IRELAND UNLIMITED CO (IE) 2021-07-28 — — EP disclosed
Send feedback